CIK 0001580149 · Non-accelerated filer<br>Smaller reporting company
BIOVIE INC.
Sign in to watch- Ticker
- BIVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 462510769
- Phone
- 775-888-3162
- Business address
- 680 W NYE LANE, SUITE 201, CARSON CITY, NV, 89703
- Former names
- NANOANTIBIOTICS, INC.
Securities
- BIVI Common stock Nasdaq
- BIVIW Warrant Nasdaq
- 8-K Event Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 32,700 shares (grant or award)
- 4 Grant or award Director acquired 34,200 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 1-A Other 1-A
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-1 Offering Registration Statement
- 10-Q Report Quarterly Report
Page 5 of 26 · 511 filings